Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COAKS: AVX001 for Actinic Keratosis
NCT05164393Phase 2Unknown
- Sponsor
- Coegin Pharma
- Start
- Nov 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AVX001 in actinic keratosis (AK), sponsored by Coegin Pharma. Status: unknown.
02
Drugs
AVX001
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT05164393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05164393.